Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aratana Therapeutics Inc (NASDAQ:PETX)

6.14
Delayed Data
As of Oct 20
 -0.24 / -3.76%
Today’s Change
4.97
Today|||52-Week Range
9.23
-14.48%
Year-to-Date

Today’s Trading

Previous close6.38
Today’s open6.46
Day’s range6.09 - 6.46
Volume434,711
Average volume (3 months)297,835
Market cap$264.0M
Dividend yield--
Data as of 4:00pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+61.22%
Earnings growth (this year)-14.65%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+5,585.99%
P/E ratioNM
Price/Sales6.57
Price/Book2.49

Competitors

 Today’s
change
Today’s
% change
NBRVNabriva Therapeutics...-0.31-4.67%
ARDXArdelyx Inc-0.20-3.51%
FBIOFortress Biotech Inc-0.31-7.23%
NLNKNewLink Genetics Cor...-0.21-2.04%
Data as of 4:00pm ET, 10/20/2017

Financials

Next reporting dateNovember 3, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$38.6M
Annual profit (last year)-$33.6M
Net profit margin-87.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Operating Officer
Brent A. Standridge
Corporate headquarters
Leawood, Kansas

Forecasts